U.S. Markets closed

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
17.88+0.58 (+3.35%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue83,337130,01422,854
Cost of Revenue---
Gross Profit83,337130,01422,854
Operating Expenses
Research Development178,15195,18789,279
Selling General and Administrative42,34129,76220,839
Non Recurring-3,59713,102
Total Operating Expenses---
Operating Income or Loss-137,1551,468-100,366
Income from Continuing Operations
Total Other Income/Expenses Net2,2935722,255
Earnings Before Interest and Taxes-134,8622,040-98,111
Interest Expense6,5676,7222,253
Income Before Tax-141,429-4,682-100,364
Income Tax Expense---70
Minority Interest---
Net Income From Continuing Ops-141,429-4,682-100,294
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-141,429-4,682-100,294
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-141,429-4,682-100,294